ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Free Communications

Adrenals and HPA Axis 1

Previous section
Pituitary, Neuroendocrinology and Puberty 1
Table of contents
Next section
Growth and Syndromes

hrp0098fc4.1 | Adrenals and HPA Axis 1

Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).

hrp0098fc4.2 | Adrenals and HPA Axis 1

11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture

hrp0098fc4.3 | Adrenals and HPA Axis 1

Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort

hrp0098fc4.4 | Adrenals and HPA Axis 1

Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric

hrp0098fc4.5 | Adrenals and HPA Axis 1

3D printed, personalized hydrocortisone for hypocortisolemia.

hrp0098fc4.6 | Adrenals and HPA Axis 1

Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more